New Market Research Report: Steba Laboratories - Product Pipeline Review - Q4 2010

Fast Market Research recommends "Steba Laboratories - Product Pipeline Review - Q4 2010" from GlobalData, now available
 
Nov. 26, 2010 - PRLog -- Global Market Direct's pharmaceuticals report, "Steba Laboratories - Product Pipeline Review - Q4 2010" provides data on the company's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. It also gives a complete picture of the company's future therapy areas of focus.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, primary and secondary research using Company's corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by Global Markets Direct's team of industry experts.

Scope

* Steba Laboratories - company overview including business description, key employees, and other facts.
* Review of current pipeline of Steba Laboratories human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, for the pharmaceutical markets across the globe.
* Product profiles for late stage and clinical stage products of Steba Laboratories with complete description of the product's developmental history, mechanism of action, clinical trials, major milestones and others.
* Recent updates of the Steba Laboratories's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to buy

* Evaluate Steba Laboratories's strategic position with total access to a detailed intelligence on its product pipeline.
* Assess the growth potential of Steba Laboratories in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Steba Laboratories's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Steba Laboratories.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Steba Laboratories and identify potential opportunities in those areas.                                
* Do deals with an understanding of the mergers and partnerships that have shaped the sector.

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/92642_steba_laboratories_produ...

Partial Table of Contents:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
3 Steba Laboratories Snapshot
3.1 Business Description
4 Steba Laboratories- Research and Development Overview
4.1 Key Therapeutic Areas
5 Steba Laboratories- Pipeline Review
5.1 Pipeline Products by Stage of Development
5.2 Pipeline Products-Monotherapy
5.3 Pipeline Products-Combination Treatment Modalities
6 Steba Laboratories Pipeline Products Glance
6.1 Steba Laboratories Phase II Pipeline
6.2 Steba Laboratories Phase I Pipeline
6.3 Steba Laboratories Pre-Clinical Pipeline
7 Steba Laboratories - Drug Profiles
7.1 Product 1
7.1.1 Product Description
7.1.2 Mechanism of Action
7.1.3 R&D Progress
8 Steba Laboratories Pipeline Analysis
8.1 Steba Laboratories Pipeline Products by Therapeutic Class
8.2 Steba Laboratories Pipeline Products by Target
8.3 Steba Laboratories Pipeline by Route of Administration
8.4 Steba Laboratories Pipeline Products by Molecule Type
9 Steba Laboratories- Recent Pipeline Updates
10 Steba Laboratories- Dormant Pipeline Projects
10.1 Feature on Dormant Projects
11 Steba Laboratories- Discontinued Pipeline Products
11.1 Discontinued Pipeline Product Profiles
11.1.1 Product 1
12 Steba Laboratories - Featured News
13 Steba Laboratories Statement
13.1 Steba Laboratories - Locations and Subsidiaries
14 Appendix
14.1 Global Markets Direct Research Methodology
14.2 Coverage
14.3 Secondary Research
14.4 Primary Research
14.5 Models
14.6 Expert Panels
14.7 Contact Us
14.8 Disclaimer

List of Tables

1.1 List of Tables
Table 1: Steba Laboratories - Key Information
Table 2: Steba Laboratories - Key Facts
Table 3: Steba Laboratories - Key Therapeutic Areas
Table 4: Steba Laboratories - Pipeline by Stage of Development, 2010
Table 5: Steba Laboratories - Monotherapy Products in Pipeline, 2010
Table 6: Steba Laboratories - Combination Treatment Modalities in Pipeline, 2010
Table 7: Steba Laboratories - Phase II Pipeline, 2010
Table 8: Steba Laboratories - Phase I Pipeline, 2010
Table 9: Steba Laboratories - Pre-Clinical Pipeline, 2010
Table 10: Steba Laboratories - Pipeline By Therapeutic Class
Table 11: Steba Laboratories - Pipeline By Target
Table 12: Steba Laboratories - Pipeline By Route of Administration
Table 13: Steba Laboratories - Pipeline By Molecule Type
Table 14: Steba Laboratories - Recent Pipeline Updates
Table 15: Steba Laboratories - Dormant Pipeline Projects

List of Figures

1.2 List of Figures
Figure 1: Steba Laboratories - Research and Development Overview
Figure 2: Steba Laboratories - Pipeline by Stage of Development, 2010
Figure 3: Steba Laboratories - Monotherapy Products in Pipeline, 2010
Figure 4: Steba Laboratories - Combination Treatment Modalities in Pipeline, 2010
Figure 5: Steba Laboratories - Pipeline By Therapeutic Class and Stage of Development
Figure 6: Steba Laboratories - Pipeline By Therapeutic Class
Figure 7: Steba Laboratories - Pipeline By Target and Stage of Development
Figure 8: Steba Laboratories - Pipeline By Target

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=9264...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
End
Source: » Follow
Email:***@fastmr.com Email Verified
Zip:01267
Tags:Steba, Laboratories, Pipeline, Therapeutic, Stage, Projects, Dormant, Route, Treatment
Industry:Medical, Research, Biotech
Location:Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Fast Market Research PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share